脑膜中动脉栓塞治疗慢性硬膜下血肿的栓塞剂选择:系统综述与Meta分析
该系统综述与Meta分析纳入22项研究,比较脑膜中动脉栓塞(382例)与手术(1373例)治疗慢性硬膜下血肿的结局。栓塞组血肿复发率4.1%,再手术率4.2%,并发症率2.6%,影像学良好结局83.1%,临床良好结局73.3%。与手术相比,栓塞显著降低再手术 odds(OR=0.48;95% CI, 23.4-99.1;P=.047)。使用Onyx栓塞者影像学复发、再手术和并发症率最低,而PVA联合弹簧圈者总体临床结局最佳。
要点
- 脑膜中动脉栓塞可作为慢性硬膜下血肿的主要或辅助治疗,安全有效。
- Onyx栓塞与较低的复发、再手术和并发症率相关。
- PVA联合弹簧圈与较好的总体临床结局相关。
核心结论
- 脑膜中动脉栓塞作为慢性硬膜下血肿的主要或辅助治疗是安全有效的。
- Onyx栓塞似乎产生较低的复发率、再手术率和并发症率。
- 颗粒和弹簧圈产生良好的总体临床结局。
研究设计与样本
- 系统综述与Meta分析,检索文献数据库从建库至2022年3月。
- 纳入22项研究,包括382例接受脑膜中动脉栓塞的患者和1373例手术患者。
- 采用随机效应模型分析复发、再手术、并发症及影像学和临床结局。
诊断标准与关键数值
- 脑膜中动脉栓塞组硬膜下血肿复发率为4.1%。
- 影像学良好结局率为83.1%,临床良好结局率为73.3%。
- 与手术相比,脑膜中动脉栓塞显著降低硬膜下血肿再手术的 odds(OR=0.48;95% CI, 23.4-99.1;P=.047)。
临床应用与阅片要点
- 在慢性硬膜下血肿治疗决策中,可考虑脑膜中动脉栓塞作为手术的替代或辅助方案。
- 选择栓塞剂时,Onyx可能降低复发、再手术和并发症风险,PVA联合弹簧圈可能改善总体临床结局。
局限性
- 纳入研究为回顾性设计。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND: Middle meningeal artery embolization is an emerging treatment option for chronic subdural hematomas.
PURPOSE: Our aim was to assess outcomes following middle meningeal artery embolization by different techniques, including in comparison with traditional surgical methods.
DATA SOURCES: We searched the literature databases from inception to March 2022.
DATA SELECTION: We selected studies reporting outcomes after middle meningeal artery embolization as a primary or adjunctive treatment for chronic subdural hematoma.
DATA ANALYSIS: We analyzed the risk of recurrence of chronic subdural hematoma, reoperation for recurrence or residual hematoma, complications, and radiologic and clinical outcomes using random effects modeling. Additional analyses were performed on the basis of whether middle meningeal artery embolization was used as the primary or adjunct treatment and by embolic agent type.
DATA SYNTHESIS: Twenty-two studies were included with 382 patients with middle meningeal artery embolization and 1373 surgical patients. The rate of subdural hematoma recurrence was 4.1%. Fifty (4.2%) patients underwent a reoperation for a recurrent or residual subdural hematoma. Thirty-six (2.6%) experienced postoperative complications. The rates of good radiologic and clinical outcomes were 83.1% and 73.3%, respectively. Middle meningeal artery embolization was significantly associated with decreased odds of subdural hematoma reoperation (OR = 0.48; 95% CI, 23.4-99.1; P = .047) compared with surgery. The lowest rates of subdural hematoma radiologic recurrence, reoperation, and complications were observed among patients receiving embolization with Onyx, whereas good overall clinical outcome occurred most commonly with combined polyvinyl alcohol and coils.
LIMITATIONS: A limitation was the retrospective design of studies included.
CONCLUSIONS: Middle meningeal artery embolization is safe and effective, either as a primary or adjunctive treatment. Treatment using Onyx seems to yield lower rates of recurrence, rescue operation, and complications whereas particles and coils produce good overall clinical outcomes.
引用
- Ku, Dmytriw, Essibayi, et al. Embolic Agent Choice in Middle Meningeal Artery Embolization as Primary or Adjunct Treatment for Chronic Subdural Hematoma: A Systematic Review and Meta-analysis. AJNR Am J Neuroradiol. 2023. PMID: 36797028. doi:10.3174/ajnr.A7796
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。